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Background
Aortic dissection causes excess mortality in Turner syn-
drome. Cross-sectional studies show increased prevalence
of aortic dilatation, the principal surrogate risk marker for
the aortic event. Increased risk has been linked with con-
genital cardiovascular abnormalities, karyotype, and
blood pressure
Purpose
To study the previously uninvestigated natural cause of
the aortopathy in Turner syndrome over time, and possi-
ble predictors of increasing aortic size
Methods
Prospective follow-up study comparing Turner syndrome
(N = 102, examined twice) with healthy age-matched
female controls (N = 65, examined once). Non-contrast,
respiratory-navigated, ECG-gated, 3D SSFP MRI analyzed
for thoracic aortic dimensions at eight positions. Bland-
Altman reproducibility testing determined the limits of
agreement. Echocardiography assessed aortic valve mor-
phology. Ambulatory blood pressures were performed
Results
Of 102 women enrolled at baseline, 11 were lost to fol-
low-up, and 80 had technically successful magnetic reso-
nance imaging scans at both baseline and follow-up.
Aortic diameters were comparable in Turner syndrome
(baseline) and controls, except from the distal aortic arch
and the aortic isthmus (classical site of coarctation) (Table
1). The prevalence of aortic dilation was significantly
higher in Turner syndrome both before and after indexing
for body surface area. In Turner syndrome, bicuspid aortic
valve, aortic coarctation, and elongated transverse aortic
arch were present in 28%, 11%, and 38%. 45, × karyotype
was seen in 61%. Blood pressures and heart rates were sig-
nificantly elevated in Turner syndrome; 23% took antihy-
pertensive medication. The mean follow-up time was 2.4
± 0.4 years (range: 1.4 to 3.5 years). The sinutubular (P =
0.02) and mid-ascending (P = 0.009) aortic diameters
increased with dilatation rates of 0.16 and 0.23 mm/year,
respectively. The remaining thorax aortic diameters
showed no statistically significant changes. None of the
currently identified factors of risk for aortic dilatation or
dissection predicted the increase. Overall, twenty-two of
80 (30%) Turner syndrome patients had an aortic diame-
ter increment above the limits of agreement, ranging from
0.7 to 2.7 mm/year (highest for the mid-ascending aorta).
No congenital anomaly or karyotype was more prevalent
in this group, where daytime and 24-hour heart rates, but
not blood pressure, were significantly higher (P < 0.03).
Antihypertensive treatment did not predict reduced
increases in aortic diameter over time
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An ascending aortopathy in adult Turner syndrome was
indicated by a general increment of sinutubular and mid-
ascending aortic size. Furthermore, a seemingly acceler-
ated dilatory aortopathy was evident in a third of the
cohort where the previously indices of risk did not clearly
predict the increase in aortic size.
Table 1: Maximum aortic diameter (mm) in Turner syndrome at inclusion and after an average follow-up time of 2.4 years compared 









(Controls versus Turner 
syndrome at baseline)




25.3 ± 4.3 25.7 ± 4.0 0.4 (0.1;0.7) 0.02 25.6 ± 2.7 0.7
Ascending aorta 27.5 ± 5.0 28.0 ± 5.1 0.6 (0.2;0.9) 0.009 26.5 ± 3.4 0.2
Distal ascending 
aorta
25.3 ± 3.6 25.2 ± 3.6 -0.1 (-0.3;0.2) 0.8 25.3 ± 2.9 0.9
Proximal aortic 
arch
23.4 ± 3.6 23.4 ± 3.4 0.1 (-0.1;0.4) 0.4 24.1 ± 2.8 0.2
Distal aortic arch 20.5 ± 2.7 20.5 ± 2.6 0.1 (-0.1;0.3) 0.5 22.8 ± 2.4 <0.0001
Aortic isthmus 19.3 ± 2.3 19.4 ± 2.3 0.1 (-0.1;0.3) 0.3 21.4 ± 2.3 <0.0001
Descending aorta 19.5 ± 2.8 19.4 ± 2.7 -0.05 (-0.2;0.1) 0.6 19.7 ± 2.3 0.7
Distal descending 
aorta
18.2 ± 2.2 18.1 ± 2.2 -0.1 (-0.2;0.1) 0.2 18.3 ± 2.3 0.7
†: Paired Student's t-test, equal variances assumed
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